Lara Heflin

773 total citations
18 papers, 619 citations indexed

About

Lara Heflin is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Immunology. According to data from OpenAlex, Lara Heflin has authored 18 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Hematology and 4 papers in Immunology. Recurrent topics in Lara Heflin's work include Cancer-related cognitive impairment studies (8 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Dementia and Cognitive Impairment Research (4 papers). Lara Heflin is often cited by papers focused on Cancer-related cognitive impairment studies (8 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Dementia and Cognitive Impairment Research (4 papers). Lara Heflin collaborates with scholars based in United States and Sweden. Lara Heflin's co-authors include Tak Takvorian, AS Freedman, F Coral, Beth E. Meyerowitz, S N Rabinowe, KC Anderson, Peter Mauch, Keith Dear, RJ Soiffer and K Blake and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Lara Heflin

15 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lara Heflin United States 9 225 193 146 112 111 18 619
Philip Murphy Ireland 13 74 0.3× 203 1.1× 61 0.4× 50 0.4× 95 0.9× 54 533
Paul Brons Netherlands 14 128 0.6× 198 1.0× 108 0.7× 96 0.9× 101 0.9× 33 692
Prabodh Shah United States 13 354 1.6× 145 0.8× 32 0.2× 150 1.3× 73 0.7× 22 860
Vijayveer Bonthapally United States 16 208 0.9× 40 0.2× 140 1.0× 65 0.6× 68 0.6× 45 663
Heather Collins United States 15 170 0.8× 305 1.6× 24 0.2× 92 0.8× 53 0.5× 46 898
Aaron Galaznik United States 13 134 0.6× 88 0.5× 121 0.8× 28 0.3× 64 0.6× 43 460
Stephanie Manson United Kingdom 13 207 0.9× 33 0.2× 164 1.1× 291 2.6× 100 0.9× 30 732
Paola Fidani Italy 13 73 0.3× 91 0.5× 94 0.6× 119 1.1× 116 1.0× 23 472
K. Yuen Australia 11 145 0.6× 291 1.5× 40 0.3× 66 0.6× 47 0.4× 19 621
Anuradha Ganesh Oman 19 60 0.3× 66 0.3× 111 0.8× 69 0.6× 119 1.1× 98 948

Countries citing papers authored by Lara Heflin

Since Specialization
Citations

This map shows the geographic impact of Lara Heflin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Heflin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Heflin more than expected).

Fields of papers citing papers by Lara Heflin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Heflin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Heflin. The network helps show where Lara Heflin may publish in the future.

Co-authorship network of co-authors of Lara Heflin

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Heflin. A scholar is included among the top collaborators of Lara Heflin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Heflin. Lara Heflin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Apple, Alexandra C., Cutter A. Lindbergh, Susan Landau, et al.. (2022). Longitudinal Trajectories of Memory Performance in Patients with Early-Stage Breast Cancer. Journal of Oncology. 2022. 1–9.
2.
Huey, Stanley J., et al.. (2017). Ethnic differences in response to directive vs. non-directive brief intervention for subsyndromal depression. Psychotherapy Research. 29(2). 186–197. 8 indexed citations
3.
Rugo, Hope S., Amy DeLuca, Lara Heflin, et al.. (2013). Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline.. Journal of Clinical Oncology. 31(26_suppl). 104–104. 2 indexed citations
4.
Heflin, Lara, Amy DeLuca, Michelle Melisko, et al.. (2013). Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits.. Journal of Clinical Oncology. 31(15_suppl). 6619–6619.
5.
Heflin, Lara, Amy DeLuca, Michelle Melisko, et al.. (2013). Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits.. Journal of Clinical Oncology. 31(26_suppl). 105–105. 1 indexed citations
6.
Rugo, Hope S., Amy DeLuca, Lara Heflin, et al.. (2013). Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline.. Journal of Clinical Oncology. 31(15_suppl). 6620–6620. 3 indexed citations
7.
Zheng, Ling, Wendy J. Mack, Helena C. Chui, et al.. (2012). Coronary Artery Disease Is Associated with Cognitive Decline Independent of Changes on Magnetic Resonance Imaging in Cognitively Normal Elderly Adults. Journal of the American Geriatrics Society. 60(3). 499–504. 62 indexed citations
8.
Heflin, Lara, Victor Laluz, Jung Yun Jang, et al.. (2011). Let's inhibit our excitement: The relationships between Stroop, behavioral disinhibition, and the frontal lobes.. Neuropsychology. 25(5). 655–665. 38 indexed citations
9.
Heflin, Lara, Beth E. Meyerowitz, Per Hall, et al.. (2005). Cancer as a Risk Factor for Long-Term Cognitive Deficits and Dementia. JNCI Journal of the National Cancer Institute. 97(11). 854–856. 87 indexed citations
10.
Heflin, Lara, Beth E. Meyerowitz, Per Hall, et al.. (2005). RESPONSE: Re: Cancer as a Risk Factor for Long-Term Cognitive Deficits and Dementia. JNCI Journal of the National Cancer Institute. 97(20). 1550–1550.
11.
Heflin, Lara, et al.. (2004). Quality of Life of Breast Cancer Survivors After a Recurrence: A Follow-Up Study. Breast Cancer Research and Treatment. 87(1). 45–57. 76 indexed citations
12.
Anderson, KC, BA Barut, Jerome Ritz, et al.. (1991). Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma. Blood. 77(4). 712–720. 7 indexed citations
13.
Anderson, KC, BA Barut, Jerome Ritz, et al.. (1991). Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma. Blood. 77(4). 712–720. 78 indexed citations
14.
Freedman, AS, Tak Takvorian, KC Anderson, et al.. (1990). Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.. Journal of Clinical Oncology. 8(5). 784–791. 147 indexed citations
15.
Anderson, KC, RJ Soiffer, Robert Delage, et al.. (1990). T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications. Blood. 76(1). 235–244. 41 indexed citations
16.
Anderson, KC, RJ Soiffer, Robert Delage, et al.. (1990). T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications. Blood. 76(1). 235–244. 37 indexed citations
17.
Freedman, AS, Jannik N. Andersen, Lara Heflin, et al.. (1989). Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function. Blood. 74(6). 2203–2211. 3 indexed citations
18.
Pedrazzini, A, AS Freedman, Janet Andersen, et al.. (1989). Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function. Blood. 74(6). 2203–2211. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip Murphy Breakdown of academic impact, for papers by Paul Brons Breakdown of academic impact, for papers by Prabodh Shah Breakdown of academic impact, for papers by Vijayveer Bonthapally Breakdown of academic impact, for papers by Heather Collins Breakdown of academic impact, for papers by Aaron Galaznik Breakdown of academic impact, for papers by Stephanie Manson Breakdown of academic impact, for papers by Paola Fidani Breakdown of academic impact, for papers by K. Yuen Breakdown of academic impact, for papers by Anuradha Ganesh
Rankless by CCL
2026